Optimum Investment Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Optimum Investment Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-75	Closed	-$4K	–	874
2021 Q3	$4K	Hold	75	–	–	﹤0.01%	770
2021 Q2	$4K	Hold	75	–	–	﹤0.01%	838
2021 Q1	$4K	Hold	75	–	–	﹤0.01%	840
2020 Q4	$4K	Hold	75	–	–	﹤0.01%	807
2020 Q3	$3K	Buy	+75	New	+$3.29K	﹤0.01%	810
2015 Q1	$42K	Sell	680 -400	-37%	-$23.7K	0.01%	549
2014 Q4	$37K	Buy	1,080 +200	+23%	+$10.9K	0.01%	576
2014 Q3	$47K	Hold	880	–	–	0.02%	489
2014 Q2	$46K	Buy	880 +280	+47%	+$13.5K	0.01%	503
2014 Q1	$28K	Buy	+600	New	+$28.3K	0.01%	462

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Centaurus Financial Anaheim, California $2.59B AUM 31.63% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Optimum Investment Advisors's XPH Position: Q4 2021 in Review

Optimum Investment Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2021, closing a stake of 75 shares — an estimated $4K sold.

Optimum Investment Advisors first reported a position in XPH in Q1 2014 and held it in 10 quarters. The position peaked at $47K in Q3 2014. 77 funds tracked by Wall St. Rank hold XPH as of Q4 2021.

Optimum Investment Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2021 after selling out during the quarter.
Optimum Investment Advisors sold 75 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2021, an estimated $4K.
Optimum Investment Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2014 and held it in 10 quarters.
Optimum Investment Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $47K in Q3 2014.
77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2021.

Based on Optimum Investment Advisors's 13F filing for Q4 2021, filed 17 Mar 2022.